BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 20801408)

  • 1. Bone marrow and circulating stem/progenitor cells for regenerative cardiovascular therapy.
    Alaiti MA; Ishikawa M; Costa MA
    Transl Res; 2010 Sep; 156(3):112-29. PubMed ID: 20801408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of progenitor endothelial cells in cardiovascular disease and upcoming therapies.
    Kawamoto A; Asahara T
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):477-84. PubMed ID: 17894361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelial progenitor cells: new perspectives and applications in cardiovascular therapies.
    Marsboom G; Janssens S
    Expert Rev Cardiovasc Ther; 2008 Jun; 6(5):687-701. PubMed ID: 18510485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frontiers in nephrology: the evolving therapeutic applications of endothelial progenitor cells.
    Tongers J; Losordo DW
    J Am Soc Nephrol; 2007 Nov; 18(11):2843-52. PubMed ID: 17942950
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cell-based cardiovascular repair and regeneration in acute myocardial infarction and chronic ischemic cardiomyopathy-current status and future developments.
    Templin C; Lüscher TF; Landmesser U
    Int J Dev Biol; 2011; 55(4-5):407-17. PubMed ID: 21553380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heart regeneration: what cells to use and how?
    Tousoulis D; Briasoulis A; Antoniades C; Stefanadi E; Stefanadis C
    Curr Opin Pharmacol; 2008 Apr; 8(2):211-8. PubMed ID: 18291721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stem cell therapy in cardiovascular disorders.
    Krause K; Schneider C; Kuck KH; Jaquet K
    Cardiovasc Ther; 2010 Oct; 28(5):e101-10. PubMed ID: 21050418
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Critical review of clinical trials of bone marrow stem cells in liver disease.
    Houlihan DD; Newsome PN
    Gastroenterology; 2008 Aug; 135(2):438-50. PubMed ID: 18585384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cardiovascular regenerative medicine at the crossroads. Clinical trials of cellular therapy must now be based on reliable experimental data from animals with characteristics similar to human's].
    Nadal-Ginard B; Torella D; Ellison G
    Rev Esp Cardiol; 2006 Nov; 59(11):1175-89. PubMed ID: 17144992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stem cell therapy for cardiac repair: benefits and barriers.
    Joggerst SJ; Hatzopoulos AK
    Expert Rev Mol Med; 2009 Jul; 11():e20. PubMed ID: 19586557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of cardiovascular risk factors on endothelial progenitor cells: limitations for therapy?
    Werner N; Nickenig G
    Arterioscler Thromb Vasc Biol; 2006 Feb; 26(2):257-66. PubMed ID: 16322535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bone-marrow-derived cells and heart repair.
    Clavel C; Verfaillie CM
    Curr Opin Organ Transplant; 2008 Feb; 13(1):36-43. PubMed ID: 18660705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adipose tissue-derived stem cells: characterization and potential for cardiovascular repair.
    Madonna R; Geng YJ; De Caterina R
    Arterioscler Thromb Vasc Biol; 2009 Nov; 29(11):1723-9. PubMed ID: 19628786
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regenerative medicine for cardiovascular disorders-new milestones: adult stem cells.
    Akar AR; Durdu S; Corapcioglu T; Ozyurda U
    Artif Organs; 2006 Apr; 30(4):213-32. PubMed ID: 16643380
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential use of endothelial progenitor cells for regeneration of the vasculature.
    Yamahara K; Itoh H
    Ther Adv Cardiovasc Dis; 2009 Feb; 3(1):17-27. PubMed ID: 19144668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Stem cell therapy for cardiovascular diseases. Experiences in Düsseldorf].
    Schannwell CM
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 8():S274-9. PubMed ID: 19085806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous bone marrow stem cell therapy for the ischemic myocardium during coronary artery bypass grafting.
    Yerebakan C; Kaminski A; Westphal B; Liebold A; Steinhoff G
    Minim Invasive Ther Allied Technol; 2008; 17(2):143-8. PubMed ID: 18465448
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Other approaches to fighting cardiovascular disease: stem cells and engineered tissue.
    Mason C
    Med Device Technol; 2006; 17(1):26-7. PubMed ID: 16483108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Contemplating the bright future of stem cell therapy for cardiovascular disease.
    Sánchez PL; San Román JA; Villa A; Fernández ME; Fernández-Avilés F
    Nat Clin Pract Cardiovasc Med; 2006 Mar; 3 Suppl 1():S138-51. PubMed ID: 16501622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of stem cells in kidney disease.
    Chhabra P; Brayman KL
    Curr Opin Organ Transplant; 2009 Feb; 14(1):72-8. PubMed ID: 19337150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.